Bioelectronics Corp (BIEL)

[seven-up]

Sure, whatever how about all the comments that can not be read? The blinders are on the post, stuck on one thing panel meeting. If that
is all needed, why all the rest? Remember the proposed order is just that, not final

Task D: Review and Consider Comments

The FDA will review and consider comments made in response to the issuance of the proposed order. The FDA will also consider changes to the proposed classification (and special controls for Class II devices) based on its review of the comments.